Immunotherapy don Ciwon huhu: Shin Yana aiki?

Wadatacce

• Ta yaya rigakafin rigakafin cutar huhu ke aiki?
• Masu hana shingen shinge
• Magungunan Monoclonal
• Alurar rigakafin cutar huhu
• Sauran rigakafi
• Wanene dan takarar kirki don rigakafin rigakafi?
• Yana aiki?
• Sakamakon sakamako na magungunan rigakafi
• Yadda ake fara magani
• Shiga cikin gwajin asibiti
• Menene hangen nesa?

Menene rigakafin rigakafi?

Immunotherapy magani ne na warkewa wanda ake amfani dashi don magance wasu nau'ikan ciwon huhu na huhu, musamman ƙananan ƙananan ƙwayoyin cuta na huhu. Wani lokaci ana kiransa ilimin ilimin halittu ko kuma ilimin ilimin halittu.

Immunotherapy yana amfani da kwayoyi waɗanda ke ƙarfafa tsarin garkuwar ku don ganowa da lalata ƙwayoyin kansa. Immunotherapy zaɓi ne na magani da zaran an gano kansar huhu. A wasu lokuta, ana amfani dashi bayan wani nau'in magani ya tabbatar da rashin nasara.

Ta yaya rigakafin rigakafin cutar huhu ke aiki?

Tsarin garkuwar ku yana aiki don kare ku daga kamuwa da cuta da rashin lafiya. Kwayoyin ku na rigakafi an horar dasu don yin niyya da kuma kai hari ga baƙon abubuwa, kamar ƙwayoyin cuta da abubuwan ƙoshin lafiya, waɗanda ke shiga jikinku.

Hakanan tsarin ku na rigakafi zai iya kaiwa hari da kuma kaiwa ƙwayoyin kansar hari. Koyaya, kwayoyin cutar kansa suna haifar da wasu ƙalubale. Suna iya bayyana kama da lafiyayyen ƙwayoyin halitta, wanda ke sanya musu wahalar ganowa. Bugu da kari, suna da saurin girma da yaduwa da sauri.

Immunotherapy na iya taimakawa haɓaka ƙarfin garkuwar ku don yaƙar ƙwayoyin kansa. Akwai nau'ikan rigakafin rigakafi wanda ke aiki ta hanyoyi daban-daban.

Masu hana shingen shinge

Tsarin ku na rigakafi yana amfani da tsarin tushen "wuraren bincike" mai gina jiki don tabbatar da cewa baya kai hari ga ƙwayoyin lafiya. Dole ne a kunna ko kashe wasu sunadarai don ƙaddamar da harin tsarin rigakafi.

Kwayoyin sankara a wasu lokuta sukan yi amfani da wadannan wuraren binciken don kaucewa lalacewa. Magungunan rigakafi na rigakafi waɗanda ke hana wuraren bincike suna yin wannan da wahala sosai.

Magungunan Monoclonal

Magungunan Monoclonal sune sunadaran da aka yi dakin gwaje-gwaje waɗanda ke ɗaure da takamaiman sassan ƙwayoyin kansa. Ana iya amfani dasu don ɗaukar magani, gubobi, ko abubuwa masu tasirin rediyo kai tsaye zuwa ƙwayoyin kansa.

Alurar rigakafin cutar huhu

Alurar rigakafin cutar kansa yana aiki iri ɗaya kamar allurar rigakafin wasu cututtuka. Suna gabatar da antigens, waxanda suke wasu qasashen ne wadanda ake amfani dasu dan haifarda wani tsarin garkuwar jiki akan kwayoyin halitta. A cikin rigakafin ciwon daji, ana iya amfani da su don kai hari kan ƙwayoyin kansa.

Sauran rigakafi

Sauran magungunan rigakafin rigakafi suna ƙarfafa garkuwar jikinka, suna mai da shi mafi tasiri wajen yaƙi da ƙwayoyin kansa.

Wanene dan takarar kirki don rigakafin rigakafi?

Masu bincike ba su fahimci wanda ke amfana daga immunotherapy kuma me yasa. ya ba da shawarar cewa maganin rigakafi na iya taimaka wa mutanen da ke da ƙananan ƙwayoyin cuta na huhu, mafi yawan nau'in sankara na huhu.

Consideredarfafawar da aka yi niyya shine zaɓin magani mafi inganci ga mutanen da ke da ƙwayar huhu waɗanda ke da wasu maye gurbi.

Immunotherapy bazai iya zama lafiya ga mutanen da ke fama da cututtukan ƙwayoyin cuta ba - irin su cututtukan Crohn, lupus, ko rheumatoid arthritis - da waɗanda ke da m ko ci gaba da cututtuka.

Yana aiki?

Immunotherapy har yanzu sabon magani ne na ciwon daji na huhu, tare da karatun da yawa a halin yanzu. Ya zuwa yanzu, sakamakon yana da kyau.

Wani bincike na matukin jirgi ya binciko tasirin allurai biyu na rigakafin rigakafi ga mutanen da ke matakin farko wanda ba karamin ƙwayar cutar sankarar huhu ba da ke shirin yin tiyata. Kodayake girman samfurin karami ne, masu bincike sun gano cewa kashi 45 cikin dari na mahalarta sun nuna matukar raguwar adadin kwayoyin cutar kansa yayin da aka cire kumburinsu.

Wani binciken kuma ya dauki mutane 616 wadanda suka kamu da cutar kansar huhu wacce ba karamar cuta ba. An zaɓi mahalarta bazuwar don karɓar koɗaɗɗen ƙwayar cuta tare da immunotherapy ko chemotherapy tare da placebo.

Daga cikin waɗanda suka karɓi rigakafin rigakafin, ƙididdigar rayuwa ta kasance kashi 69.2 cikin watanni 12. Sabanin haka, rukunin wuribo yana da kimanin kimanin rayuwa na watanni 12 na kashi 49.4.

Immunotherapy an riga an canza yanayin kulawa don mutanen da ke fama da cutar huhu. Koyaya, ba cikakke bane. A cikin binciken na ƙarshe, mutanen da suka karɓi jiyyar cutar sankara tare da rigakafin rigakafi sun iya fuskantar mummunan illa kuma sun kawo ƙarshen maganin su da wuri idan aka kwatanta da rukunin wuribo.

Sakamakon sakamako na magungunan rigakafi

Magungunan rigakafi na iya haifar da sakamako masu illa. Wasu daga cikin waɗannan sun haɗa da:

• maƙarƙashiya
• gudawa
• gajiya
• ƙaiƙayi
• ciwon gwiwa
• rashin ci
• tashin zuciya
• rashes na fata

A wasu lokuta, maganin rigakafi yana haifar da rigakafin tsarin garkuwar jiki akan gabobin ku. Wannan na iya haifar da mummunan sakamako kuma wani lokacin na barazanar rayuwa.

Idan kana shan magani na rigakafi, ya kamata ka bada rahoton sabbin illoli nan take. Likitanku zai iya taimaka muku yanke shawara idan kuna buƙatar dakatar da magani.

Yadda ake fara magani

Immunotherapy har yanzu ba ta zama gama gari ba kamar sauran hanyoyin magance cutar kansa. Koyaya, da yawa likitoci yanzu suna samar dashi. Yawancin waɗannan likitocin likitocin kano ne, wanda ke nufin sun ƙware a maganin kansa.

Don neman likita wanda zai iya ba da rigakafin rigakafin rigakafi, tuntuɓi cibiyar kiwon lafiya da ta ƙware kan maganin kansa. Hakanan zaka iya tambayar likitanka don shawarwarin.

Immunotherapy na iya zama mai tsada kuma koyaushe ba inshora ke rufe shi ba. Ya dogara da wurin da kake zaune da kuma kamfanin inshorar naka.

Shiga cikin gwajin asibiti

Yawancin magungunan rigakafi suna ci gaba da gwaji na asibiti. Wannan yana nufin ba su sami izinin Hukumar Abinci da Magunguna ta Amurka ba kuma ba za a iya ba da umarnin likitoci ba.

Masu bincike suna amfani da gwaji na asibiti don auna yadda tasiri ɗaya ko fiye magunguna suke. Mahalarta yawanci masu sa kai ne. Idan kuna son shiga cikin gwaji na asibiti, likitanku na iya taimaka muku ƙarin koyo, gami da haɗari da fa'idojin shiga.

Menene hangen nesa?

Lokaci ne kawai zai bayyana yadda tasirin maganin rigakafi yake wajen magance cutar sankarar huhu. A yanzu, yana bayyana rigakafin rigakafi na iya inganta hangen nesa ga mutanen da ke da ƙananan ƙwayoyin cuta na huhu. Bincike yana ci gaba da sauri amma sakamakon lokaci mai tsawo zai ɗauki shekaru.